1.
Pediatr Infect Dis J
; 40(7): e259-e262, 2021 07 01.
Article
in English
| MEDLINE | ID: covidwho-1258812
ABSTRACT
Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection is an infrequent and poorly understood illness. It can present as severe multiorgan failure in children, potentially lethal. Immunomodulation is the empiric treatment because a dysregulated immune response is the primary pathophysiologic mechanism. We present an infant with severe MIS-C, refractory to usual treatment, successfully treated with plasmapheresis.